Valuation: Molecure S.A.

Market Cap 121M 31.78M 27.84M 25.85M 23.75M 44.76M 3.07B 45.42M 308M 1.5B 119M 117M 5.18B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 89.63M 23.63M 20.71M 19.22M 17.66M 33.28M 2.28B 33.77M 229M 1.12B 88.71M 86.8M 3.85B EV / Sales 2025
19.2x
EV / Sales 2026 * 9.5x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
Current month+6.36%
1 month+2.81%
3 months+2.63%
6 months-18.41%
Current year-11.36%
1 week 5.6
Extreme 5.6
5.9
1 month 5.36
Extreme 5.36
6.1
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.06
3 years 4.98
Extreme 4.98
25.5
5 years 4.98
Extreme 4.98
48
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 03/01/2023
Director TitleAgeSince
Director/Board Member - 30/06/2021
Chairman 38 01/06/2023
Director/Board Member - 14/01/2022
Date Insider Type Main position Quantity % Market Cap.
12/22/23 A Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-2.17%-69.78% 31.78M
-0.43%-4.26%+52.09%+85.69% 55.27B
-0.24%+1.04%+55.76%+54.21% 54.15B
-1.82%-2.89%+3.61%+405.88% 23.11B
-0.54%-0.17%-17.60%-15.43% 23.22B
+0.88%-0.46%+36.14%-3.48% 20.33B
+3.16%+0.79%+37.98%-31.36% 17.91B
+0.97%-0.57%+38.53%+551.00% 15.76B
+0.43%-10.61%+175.63%+299.61% 15B
-2.03%-1.03%+23.63%+179.23% 13.82B
Average -0.02%-1.49%+40.36%+145.56% 23.86B
Weighted average by Cap. -0.14%-1.05%+44.24%+132.92%

Financials

2025 2026 *
Net sales 3.9M 1.03M 901K 836K 769K 1.45M 99.22M 1.47M 9.96M 48.55M 3.86M 3.78M 168M 13.1M 3.45M 3.03M 2.81M 2.58M 4.86M 333M 4.94M 33.47M 163M 12.97M 12.69M 563M
Net income -21.2M -5.59M -4.9M -4.55M -4.18M -7.87M -539M -7.99M -54.17M -264M -20.98M -20.53M -912M -71.6M -18.88M -16.54M -15.36M -14.11M -26.59M -1.82B -26.98M -183M -891M -70.87M -69.34M -3.08B
Net Debt -30.9M -8.15M -7.14M -6.63M -6.09M -11.48M -786M -11.64M -78.95M -385M -30.58M -29.92M -1.33B 3.9M 1.03M 901K 836K 769K 1.45M 99.22M 1.47M 9.96M 48.55M 3.86M 3.78M 168M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
22/07/26 PLN 5.850 0.00% 9,815
21/07/26 PLN 5.850 0.00% 7,067
20/07/26 PLN 5.850 +0.86% 22,785
17/07/26 PLN 5.800 -0.68% 7,910
16/07/26 PLN 5.840 -0.17% 19,738
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.850PLN
Average target price
12.45PLN
Spread / Average Target
+112.82%

Quarterly revenue - Rate of surprise